Molecular Biomarkers of Neovascular Age-Related Macular Degeneration With Incomplete Response to Anti-Vascular Endothelial Growth Factor Treatment

• Main Authors: Irmela Mantel (Author), Angelica Borgo (Author), Jacopo Guidotti (Author), Edwige Forestier (Author), Olga Kirsch (Author), Yasmine Derradji (Author), Patrice Waridel (Author), Frédéric Burdet (Author), Florence Mehl (Author), Claude Schweizer (Author), Raphaël Roduit (Author)
• Format: Book
• Published: Frontiers Media S.A., 2020-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The standard treatment for neovascular age-related macular degeneration (nAMD) consists of intravitreal anti-vascular endothelial growth factors (VEGF). However, for some patients, even maximal anti-VEGF treatment does not entirely suppress exudative activity. The goal of this study was to identify...